California-based biotech company, International Stem Cell, will host a conference call Friday, August 9, 2013, to discuss the company’s financial results for the three-month and six-month periods ended June 30, 2013.
Executive Vice President Dr. Simon Craw and Interim CFO Jay Novak will host the conference call, also available via Web cast. To attend the call, please use the dial in information below:
Date: Friday, August 9, 2013
Time: 11 a.m. Eastern Time
Conference Line (U.S.): 1-877-317-6776
International Dial-In: 1-412-317-6776
Conference ID: 10032411
Webcast: http://webcast.mzvaluemonitor.com/Cover.aspx?PlatformId=1545
Please dial in at least 10-minutes before the call to ensure timely participation.
A playback of the call will be available until 11 a.m. ET August 16, 2013. To listen, call 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10032411.
International Stem Cell is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs), thereby avoiding controversial issues associated with the use or destruction of viable human embryos. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), as well as stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com).
For additional information, visit www.InternationalStemCell.com
International Stem Cell Corp. (ISCO) Schedules Q2 Earnings Conference Call, Webcast
California-based biotech company, International Stem Cell, will host a conference call Friday, August 9, 2013, to discuss the company’s financial results for the three-month and six-month periods ended June 30, 2013.
Executive Vice President Dr. Simon Craw and Interim CFO Jay Novak will host the conference call, also available via Web cast. To attend the call, please use the dial in information below:
Date: Friday, August 9, 2013
Time: 11 a.m. Eastern Time
Conference Line (U.S.): 1-877-317-6776
International Dial-In: 1-412-317-6776
Conference ID: 10032411
Webcast: http://webcast.mzvaluemonitor.com/Cover.aspx?PlatformId=1545
Please dial in at least 10-minutes before the call to ensure timely participation.
A playback of the call will be available until 11 a.m. ET August 16, 2013. To listen, call 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10032411.
International Stem Cell is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs), thereby avoiding controversial issues associated with the use or destruction of viable human embryos. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), as well as stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com).
For additional information, visit www.InternationalStemCell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.netInternational Stem Cell Corp. (ISCO) Schedules Q2 Earnings Conference Call, Webcast
California-based biotech company, International Stem Cell, will host a conference call Friday, August 9, 2013, to discuss the company’s financial results for the three-month and six-month periods ended June 30, 2013.
Executive Vice President Dr. Simon Craw and Interim CFO Jay Novak will host the conference call, also available via Web cast. To attend the call, please use the dial in information below:
Date: Friday, August 9, 2013
Time: 11 a.m. Eastern Time
Conference Line (U.S.): 1-877-317-6776
International Dial-In: 1-412-317-6776
Conference ID: 10032411
Webcast: http://webcast.mzvaluemonitor.com/Cover.aspx?PlatformId=1545
Please dial in at least 10-minutes before the call to ensure timely participation.
A playback of the call will be available until 11 a.m. ET August 16, 2013. To listen, call 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10032411.
International Stem Cell is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs), thereby avoiding controversial issues associated with the use or destruction of viable human embryos. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), as well as stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com).
For additional information, visit www.InternationalStemCell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.netInternational Stem Cell Corp. (ISCO) Schedules Q2 Earnings Conference Call, Webcast
California-based biotech company, International Stem Cell, will host a conference call Friday, August 9, 2013, to discuss the company’s financial results for the three-month and six-month periods ended June 30, 2013.
Executive Vice President Dr. Simon Craw and Interim CFO Jay Novak will host the conference call, also available via Web cast. To attend the call, please use the dial in information below:
Date: Friday, August 9, 2013
Time: 11 a.m. Eastern Time
Conference Line (U.S.): 1-877-317-6776
International Dial-In: 1-412-317-6776
Conference ID: 10032411
Webcast: http://webcast.mzvaluemonitor.com/Cover.aspx?PlatformId=1545
Please dial in at least 10-minutes before the call to ensure timely participation.
A playback of the call will be available until 11 a.m. ET August 16, 2013. To listen, call 1-877-344-7529 within the United States or 1-412-317-0088 when calling internationally. Please use the replay pin number 10032411.
International Stem Cell is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs), thereby avoiding controversial issues associated with the use or destruction of viable human embryos. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), as well as stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com).
For additional information, visit www.InternationalStemCell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment